ライフサイエンスコーパス: extremity

1 l (tibial nerve) nerve segments of the lower extremity.

2 the upper and lower back and from the lower extremity.

3 l pain or functional impairment of the upper extremity.

4 ications for the rehabilitation of the upper extremity.

5 minor coat protein and TGB1 attached to one extremity.

6 ing plaster cast immobilization of the lower extremity.

7 lead to amputation of a portion of the lower extremity.

8 ith plaster cast immobilization of the lower extremity.

9 and 12 (22%) underwent amputation of a lower extremity.

10 ith conventional EBRT for primary STS of the extremity.

11 ecause of fever and erythema on the face and extremity.

12 functional disability involving the affected extremity.

13 taneous metastatic disease of the left lower extremity.

14 sions were detected in clinically unaffected extremities.

15 ent warmth, erythema, and pain in the distal extremities.

16 of limbs is the presence of digits at their extremities.

17 ttled pigmentation on the trunk and proximal extremities.

18 t evaluated deficits in both upper and lower extremities.

19 that results in ischemia mostly in the lower extremities.

20 nce in systolic blood pressure between upper extremities.

21 y a postural and kinetic tremor of the upper extremities.

22 n patients with soft-tissue sarcoma in their extremities.

23 e major conduit arteries supplying the lower extremities.

24 umors scattered over the chest, abdomen, and extremities.

25 ive defects larger than 8 mm on the trunk or extremities.

26 for circular or oval wounds on the trunk and extremities.

27 remities, including the weight-bearing lower extremities.

28 ntary movements of the right upper and lower extremities.

29 into a shell-like structure by loading their extremities.

30 s from the dorsolateral pole to ventromedial extremities.

31 of the body, with predominance for the lower extremities.

32 nderstudied topic, particularly in the lower extremities.

33 confluent plaques predominantly on the lower extremities.

34 ons that covered places other than the lower extremities.

35 ent warmth, erythema, and pain in the distal extremities.

36 ical resection of soft-tissue sarcoma of the extremities.

37 58%) than visceral-mesenteric (31%) or upper extremity (10%).

38 aris telangiectodes of Majocchi on the lower extremities 2 months after initiating isotretinoin for t

39 carotid (53%), lower extremity (41%), upper extremity (3%), and aortic disease (33%).

40 g and was classified as carotid (53%), lower extremity (41%), upper extremity (3%), and aortic diseas

41 s (face, 41.0 vs 61.0 days [P = .001]; upper extremities, 46.0 vs 69.0 days [P = .003]).

42 SEEs more frequently involved the lower extremity (58%) than visceral-mesenteric (31%) or upper

43 e most frequently injured site was the lower extremity (70.2%), and 47.9% of all injuries were Gustil

44 For the face and upper extremities, a significantly higher percentage of patien

45 d, while polarity markers are lost from cell extremities, actin patches and cables are reorganized in

46 ltiple lesions on sun-exposed areas of their extremities after a median of 13 months (range, 4-18 mon

47 ensation to functional recovery of the upper extremity after a unilateral brain lesion.

48 of global spinal balance together with lower extremity alignment should be strongly recommended.

49 ately 2-fold higher risk of below-knee lower extremity amputation (0.17 versus 0.09 events per 100 pe

50 remains unclear whether the below-knee lower extremity amputation risk extends across the class of me

51 ripheral arterial revascularization or lower extremity amputation, 4.6% died, and the median cost of

52 cs System to compare the incidences of lower-extremity amputation, end-stage renal disease, acute myo

53 r events and higher risk of below-knee lower extremity amputation.

54 ratory safety end point was below-knee lower extremity amputation.

55 Over 60% of lower extremity amputations are performed in patients with dia

56 About 85% of lower extremity amputations in diabetes are attributed to deep

57 Lower extremity amputations were similarly increased in the se

58 sticity of the primary motor cortex in upper-extremities amputees and to determine if the acquisition

59 muscle hernias are not uncommon in the lower extremities and are a rare cause of chronic leg pain.

60 ratotic-affected skin on the upper and lower extremities and trunk, and identified a single, protein-

61 zes were identified on the scalp, trunk, and extremities and were reported to have been present since

62 40 to lower than 50 Gy appears adequate for extremities and/or trunk stage I to III MCC, with OS equ

63 ears or older with stage I to III MCC of the extremities and/or trunk treated with definitive surgery

64 f VTE after cast immobilization of the lower extremity and (2) to develop a clinical prediction tool

65 ation in long-term memory, enhanced attitude extremity and accessibility, enhanced attitude impact on

66 agnosed when schwannomas are restricted to 1 extremity and is thought to be caused by genetic mosaici

67 Those are the Fugl-Meyer Upper Extremity and Lower Extremity scales, Wolf Motor Functio

68 had plaster cast immobilization of the lower extremity and that blood was drawn 3 mo after the thromb

69 atory status (McNemar test, P < .001), lower extremity and total motor scores (Wilcoxon signed rank t

70 ted Injury Scale (for head, thorax, abdomen, extremities), and occurrence of prehospital shock.

71 with an eczematous dermatitis on her torso, extremities, and buttocks and who subsequently developed

72 ay/intellectual disability (DD/ID), abnormal extremities, and hirsutism.

73 characterized by a long narrow chest, short extremities, and variable occurrence of polydactyly.

74 le brachial index >/=1.4 who underwent lower extremity angiograms within 1 year were included.

75 rtance: Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (aka "pse

76 Inflammatory dermatoses of the lower extremity are often misdiagnosed as cellulitis (aka "pse

77 , it is hopeful that we will treat the lower extremity arteries according to segments, taking into ac

78 RNA is produced and bears the same 5' and 3' extremities as in wild-type plants.

79 t are compatible with the body's abdomen and extremities, as well as the deep brain, suggesting that

80 enced immediate reduction in upper- to lower-extremity blood pressure difference with sustained impro

81 prospective study including 21 patients with extremity bone tumours, margins as seen on various MRI s

82 Lower extremity bypass grafting is most successful with a good

83 tic peripheral artery disease includes lower extremity bypass surgery (LEB) and peripheral endovascul

84 ity for patients undergoing colectomy, lower extremity bypass, or all surgical procedures.

85 erythema that typically affects the proximal extremities, can be disfiguring, and is often resistant

86 modalities, i.e. brain parenchyma, bones and extremities, can be evaluated in one examination.

87 rge urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012

88 rge urban hospital with a diagnosis of lower extremity cellulitis between June 2010 and December 2012

89 lusions and Relevance: Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessa

90 Misdiagnosis of lower extremity cellulitis is common and may lead to unnecessa

91 in patients admitted for treatment of lower extremity cellulitis.

92 in patients admitted for treatment of lower extremity cellulitis.

93 mitted from the ED with a diagnosis of lower extremity cellulitis.

94 mitted from the ED with a diagnosis of lower extremity cellulitis.

95 ositis, conjunctivitis, lymphadenopathy, and extremity changes are superficially unexceptional, and r

96 ery we summarise the available data on acute extremity compartment syndrome of the upper and lower ex

97 is no consensus about the way in which acute extremity compartment syndromes should be diagnosed.

98 pressed and confirmed entry into all 4 lower extremity compartments.

99 Together, head and neck (24%) and back and extremity conditions (32%) were responsible for more tha

100 viations were determined for the given lower-extremity CT examinations for all age groups and for bot

101 Pediatric lower extremity deep vein thrombosis (LE-DVT) can lead to post

102 nce, the characterization of pediatric upper extremity deep vein thrombosis (UE-DVT) and of UE postth

103 DT) in the treatment of acute proximal lower-extremity deep vein thrombosis is increasing in the Unit

104 atients were hospitalized for proximal lower-extremity deep vein thrombosis, and 3649 patients (4.1%)

105 on in the setting of acute and chronic lower extremity deep venous disease.

106 y has not been evaluated for suspected upper extremity deep venous thrombosis (UEDVT).

107 e spectrum of ipsilateral thoracic and upper extremity deformities.

108 Ventilation-perfusion imaging and lower extremity Doppler ultrasonography were performed (images

109 Patients underwent a screening lower-extremity duplex ultrasound approximately 1 month after

110 In a clinical study, 38 patients with lower extremity DVT or controls undergoing FDG-PET were analyz

111 Upper-extremity dysfunction was not associated with SPA incomp

112 a better mechanistic understanding of lower extremity endovascular treatment using tools such as int

113 bridges identified those patients with lower extremity evoked potentials and better clinical recovery

114 ed CCC as a diffuse rash involving the body, extremities, face or scalp, and/or funisitis, presenting

115 uring extremity vascular exposures and lower extremity fasciotomy in fresh cadavers before and after

116 r = 0.466, 95%CI: 0.432~0.500), except lower extremity fat (r = 0.088, 95%CI: -0.116~0.285).

117 quently recommended radiography of the lower extremities ( Fig 3 ).

118 These included stroke, lower extremity fracture, lower extremity joint replacement, d

119 spinal cord paralysis, venous injury, lower extremity fracture, pelvic fracture, central line, intra

120 Head injuries (46.8% of patients) and extremity fractures (31.2% of patients) were the most co

121 dmitted to a level 1 trauma center with open extremity fractures from September 22, 2008, through Jun

122 heter placement, presence of pelvic or lower extremity fractures, and major surgery), and the points

123 fracture healing or weight bearing for lower extremity fractures.

124 Motor impairment as indexed by the Upper Extremity Fugl Meyer assessment was significantly reduce

125 ver ischemic stroke patients using the Upper-Extremity Fugl-Meyer (UE-FM) Scale to measure motor impa

126 e SPA is not associated with a loss of upper-extremity function after transradial catheterization.

127 elded 115 clinical trials of upper and lower extremity function in chronic stroke that used a total o

128 ence to identify measures of upper and lower extremity function used to date as outcomes in trials wi

129 Upper-extremity function was assessed at baseline and 2-year f

130 activity limitation assessed using the Lower Extremity Functional Scale (score range, 0-80; higher sc

131 the transplantation of face, bilateral upper extremities, heart, 1 lung, liver (split for 2 recipient

132 Upper extremity hemiplegia is a common consequence of unilater

133 uloskeletal pain into lower back pain, lower extremity (hips, knees, and feet/ankles combined) pain,

134 that other painful conditions of the distal extremities (ie, neuropathy related to human immunodefic

135 th motor stroke and primarily moderate upper extremity impairment, use of a structured, task-oriented

136 th motor stroke and primarily moderate upper extremity impairment.

137 Using a rat model of upper extremity impairments after ischemic stroke, we examined

138 d cortical lesions had the most severe upper extremity impairments, particularly somatosensory functi

139 compartment syndrome of the upper and lower extremities in adults and children, discuss the underlyi

140 keletal muscles weakness and numbness of the extremities in exposed human and laboratory animals.

141 time frame for revascularization of procured extremities in limb transplantation.

142 lphalan is an effective treatment option for extremity in-transit melanoma but is toxic and technical

143 ons), retinal manifestations, and defects on extremities including congenital contractures and hypert

144 in patients with early-onset pain in distal extremities including joints and gastrointestinal distur

145 y skin lesions involving the head, trunk and extremities, including palms of hands and soles of feet.

146 T scanner has been developed for imaging the extremities, including the weight-bearing lower extremit

147 his supplementary interaction at the aptamer extremities induced stabilizing effects on the ternary c

148 e 55 incident cases (98%) of bilateral lower extremity inflammatory lymphedema occurred during the fi

149 rainees (0.4%) who developed bilateral lower extremity inflammatory lymphedema that occurred during t

150 were ruled out as sources of bilateral lower extremity inflammatory lymphedema.

151 for every confirmed case of bilateral lower extremity inflammatory lymphedema.

152 for interrogation of 124 wound samples from extremity injuries in combat-injured U.S. service member

153 pressure for all patients who have high-risk extremity injuries, whereas others suggest aggressive su

154 otopic ossification (HO) after blast-related extremity injury and traumatic injuries, respectively.

155 a rat model of blast-related, polytraumatic extremity injury.

156 Acute compartment syndrome of the extremities is well known, but diagnosis can be challeng

157 reatment of soft tissue sarcoma (STS) of the extremity is increasing, but no large-scale direct compa

158 Lower extremity ischemia is also associated with pathophysiolo

159 l limb ischemia, marked by intractable lower extremity ischemic rest pain and tissue loss, is a highl

160 e therapeutic effect on both upper and lower extremities, its role in motor control and coordination

161 Lower extremity joint replacement at a BPCI-participating hosp

162 ee-for-service beneficiaries who had a lower extremity joint replacement at a BPCI-participating hosp

163 There were 29441 lower extremity joint replacement episodes in the baseline per

164 e, Medicare payments declined more for lower extremity joint replacement episodes provided in BPCI-pa

165 (95% CI, 5.8%-5.9%) for patients with lower extremity joint replacement to 18.8% (95% CI, 18.8%-18.9

166 uded stroke, lower extremity fracture, lower extremity joint replacement, debility, neurologic disord

167 occal cassette chromosome mec (SCCmec) right-extremity junction (MREJ) region among 907 methicillin-r

168 79 patients (41% female) who underwent lower extremity (LE)-PVI from 2004 to 2009 at 16 hospitals par

169 We found that local image fragments such as extremities (limbs), curved boundaries, and parts of the

170 In this study, upper extremity moles, a higher ability to achieve a tan, and

171 en patients (11.1%) had calcinosis, with the extremities most commonly involved.

172 practice for patients with stroke with upper extremity motor deficits.

173 ore enrolment and had mild-to-moderate upper extremity motor impairment, non-immersive virtual realit

174 The primary outcome was upper extremity motor performance measured by total time to co

175 erlapping representations of upper and lower extremity movement kinematics in subthalamic units and o

176 A full lower extremity MRI and a detailed knee MRI were taken.

177 ia-related pathophysiologic changes in lower extremity muscles and peripheral nerves of people with P

178 progresses to involve other lower and upper extremities' muscles, with marked sparing of the quadric

179 ies and microvascular landmarks in the lower extremities of 10 healthy volunteers.

180 ctivity of somatosensory gating in the lower extremities of healthy human participants.

181 hat assembly of this adhesion complex at the extremities of migrating oligodendroglial processes prom

182 ed a bivalent signaling design where the two extremities of one split aptamer fragment were conjugate

183 s of connective tissue nevi on the trunk and extremities of patients with tuberous sclerosis complex.

184 onfer protection than those that bind at the extremities of the antigen.

185 tial recondensation of ices near the coldest extremities of the cap.

186 -N transition with the I and N phases at the extremities of the channel, starting from an initially s

187 application of an electric potential to the extremities of the device.

188 Similar structures of covalently linked extremities of the linear DNA genome are found in the Af

189 ost factors that interact with the 5' and 3' extremities of the norovirus RNA genome.

190 a model in which gRNA is derived from the 5' extremity of a primary molecule by uridylation-induced,

191 g a previously unmapped origin toward the 5' extremity of chromosome 1.

192 We reveal that the N-terminal extremity of Galphas contains a ubiquitin-interacting mo

193 to handedness can affect the development and extremity of spatial biases, potentially conferring resi

194 ghout the live cell with DNA clusters in the extremity of the cell and peri-nuclear areas.

195 ndary, slow expansion phase during which the extremity of the circular plate seeks contact with the m

196 HSPCs, the lysine residues on the N-terminal extremity of Vectofusin-1, a hydrophilic angle of 140 de

197 following resection of localized MCC of the extremities or trunk.

198 rer vibration perception in the distal lower extremities (P = .008, adjusting for age, height, and te

199 the adjusted hazard ratio of ischemic lower-extremity PAD (1.54 [95% CI, 1.14-2.10]) (p = 0.005).

200 During the follow-up period, ischemic lower-extremity PAD developed in 24.4% of hemodialysis patient

201 ciated with the occurrence of ischemic lower-extremity PAD in hemodialysis patients.

202 scularization strategy for symptomatic lower extremity PAD is not established.

203 scularization strategy for symptomatic lower extremity PAD is not established.

204 hemodialysis patients in whom ischemic lower-extremity PAD occurred (3.03% [IQR, 2.36-4.54], n = 22)

205 ients until the occurrence of ischemic lower-extremity PAD.

206 s were ODI change at 1 year, change in lower extremity pain (measured on a 0-10 scale; higher scores

207 21 to 64 years with moderate to severe acute extremity pain enrolled from July 2015 to August 2016.

208 ain-free participants, those reporting lower extremity pain had greater odds of having poor physical

209 ain-free participants, those reporting lower extremity pain had significantly lower Impact of Weight

210 For patients presenting to the ED with acute extremity pain, there were no statistically significant

211 Eighty-five adults with upper extremity paresis >/=6 months poststroke were randomized

212 cerebral artery infarction, leading to upper extremity paresis, paresthesia, and sensory loss.

213 nal aortic diameter is associated with lower-extremity peripheral artery disease (LE-PAD).

214 proving walking ability in people with lower extremity peripheral artery disease (PAD) are unclear.

215 Lower extremity peripheral artery disease (PAD) is frequently

216 ic kidney disease is a risk factor for lower-extremity peripheral artery disease.

217 23,934 consecutive patients undergoing lower extremity peripheral vascular interventions between Janu

218 Participants' lower-extremity physical ability was assessed every 3 years (1

219 icantly improved exercise capacity and lower extremity power.

220 (MCD) or spinal muscular atrophy with lower extremity predominance (SMALED), as well as three mutati

221 model for spinal muscular atrophy with lower extremity predominance and a combination of live-cell im

222 ein cause spinal muscular atrophy with lower extremity predominance, Charcot-Marie-Tooth disease and

223 ures of BICD2 spinal muscular atrophy, lower extremity predominant are consistent with a pathological

224 BICD2 spinal muscular atrophy, lower extremity predominant most commonly presents with delaye

225 Spinal muscular atrophy, lower extremity-predominant, is characterized by lower limb mu

226 ry of peripheral artery disease of the lower extremities (previous peripheral bypass surgery or angio

227 imerization interface and an important C-ter extremity providing the first in-depth functional archit

228 ts per year attributed to misdiagnosed lower extremity pseudocellulitis.

229 ominantly to the location to which the upper extremity reached, and the second related to the object

230 r an equivalent or a lower dose of UCC upper extremity rehabilitation.

231 the musculoskeletal kinematics of the lower extremities remain poorly understood.

232 nning both the proximal and the distal upper extremity representation in caudal M1.

233 atients enrolled based on the previous lower extremity revascularization criterion.

234 ntervention after endovascular or open lower extremity revascularization for propensity-score matched

235 ntervention after endovascular or open lower extremity revascularization for propensity-score matched

236 ent characteristics accounted for 12% (lower extremity revascularization) to 57% (esophagectomy) of t

237 e-brachial index </=0.80 or a previous lower extremity revascularization.

238 fore receiving 3 weeks of standardized upper extremity robotic therapy.

239 orable outcome was shown on physical Toronto Extremity Salvage Score, SF-36 Physical Component Summar

240 g sarcoma trials was assessed by the Toronto Extremity Salvage Score, Short-Form Health Survey (SF-36

241 commends that the Fugl-Meyer Upper and Lower Extremity scales be used as primary outcomes in interven

242 th chronic stroke Fugl-Meyer Upper and Lower Extremity scales showing the strongest evidence for vali

243 are the Fugl-Meyer Upper Extremity and Lower Extremity scales, Wolf Motor Function Test, Action Resea

244 emic stroke and a motor deficit of the upper extremity score of 3 or more (measured with the Chedoke-

245 ter visceral-mesenteric than lower- or upper-extremity SEE (55%, 17%, and 9%, respectively, P</=0.000

246 bilateral optic disc edema with distal lower-extremity sensory and motor deficits and electrodiagnost

247 rogramme of structured, task-oriented, upper extremity sessions (ten sessions, 60 min each) of either

248 ped pruritic, brown plaques on the trunk and extremities showing a distinctive epidermal hyperplasia

249 the patients admitted (66.6%) suffered lower extremity soft tissue and bony injuries, and 31 had evid

250 l to assess late toxicities in patients with extremity soft tissue sarcoma (STS) treated with preoper

251 re- vs Postoperative Radiotherapy in Curable Extremity Soft Tissue Sarcoma) trial receiving preoperat

252 tentially curative for primary nonmetastatic extremity soft tissue sarcomas.

253 alities of the face, the oral cavity and the extremities, some due to mutations in proteins of the tr

254 neurologic examination with preserved lower extremity strength and sphincter tone.

255 endurance), isometric knee extension (lower extremity strength), unipedal stance time (static balanc

256 (n = 817) of educational workshops and upper-extremity stretching.

257 ve adult patients with primary nonmetastatic extremity STS were treated with limb-sparing surgery and

258 eduction of late toxicities in patients with extremity STS who were treated with preoperative IGRT an

259 dy are appropriate for preoperative IGRT for extremity STS.

260 rapy for Primary Soft Tissue Sarcomas of the Extremity) study are appropriate for preoperative IGRT f

261 thyroid, lung, inguinal hernia, and face and extremity surgeries with clean or clean-contaminated wou

262 muscle tone and increased muscle tone in her extremities; the latter was more severe.

263 .58%), infection (1.34% versus 3.07%), upper extremity thrombosis (0.77% versus 0.96%), pulmonary emb

264 d no evidence of pulmonary embolism or lower extremity thrombus.

265 gned patients who had an open fracture of an extremity to undergo irrigation with one of three irriga

266 Structured, task-oriented upper extremity training (Accelerated Skill Acquisition Progra

267 sychosocial evaluation and outcomes of upper extremity transplant recipients: required domains of the

268 Psychiatric complications in upper extremity transplanted patients have been reported by th

269 Volumetric muscle loss (VML) resulting from extremity trauma presents chronic and persistent functio

270 ass vs Angioplasty and Stenting of the Lower Extremity Trial (ROBUST) is the first prospective random

271 ied anatomical sites (face, scalp, and upper extremities) twice daily for 4 consecutive days.

272 sia gyiorum, in a patient with chronic lower-extremity ulcers, and we review the literature on this u

273 b ischemia, ischemic rest pain, gangrene, or extremity ulcers.

274 ents with malignant melanoma on the trunk or extremities (upper and lower) who were scheduled to unde

275 All subjects reported pain and heat in the extremities (usually feet and/or hands), with pain attac

276 Extremity vascular and fasciotomy performance evaluation

277 omy (28.8%), arthroplasty (18.8%), and lower extremity vascular bypass (36.4%).

278 throplasty, ventral hernia repair, and lower extremity vascular bypass.

279 rom 3.8% for hysterectomy to 14.9% for lower extremity vascular bypass.

280 Performance was measured during extremity vascular exposures and lower extremity fasciot

281 andomized study of patients undergoing lower extremity vascular procedures from 2011 to 2014.

282 ting scale, kinematic analyses of peak upper extremity velocity, positron emission tomography imaging

283 ual burden caused by acute and chronic lower extremity venous disease is considerable.

284 orectal surgery underwent preoperative lower extremity venous duplex (LEVD) immediately before surger

285 From 14056 lower-extremity venous duplex studies, we identified 697 patie

286 At examination, strength in both lower extremities was slightly reduced, sensation and reflexes

287 of EIM phase ratio trajectories in the upper extremity was observed by 6 months of -0.074/month, p =

288 The extremity was the most common anatomic site injured (74.

289 Lower extremity weakness predominated (46 [73%]).

290 A brief 4-item scale encompassing lower-extremity weakness, cognitive impairment, anemia, and hy

291 weight loss, headache, photophobia, seizure, extremity weakness, or sensory disturbance.

292 week of low back pain and progressive lower extremity weakness.

293 the illness and can occur without preceding extremity weakness.

294 ed respiratory involvement without report of extremity weakness.

295 rs that cause progressive debilitating focal extremity weakness.

296 discarded terminal hairs from the trunk and extremities were collected from 2 adult volunteers.

297 lusters locate relatively closer to the cell extremities, whereas in anucleated cells (deletion mutan

298 in the head and neck, on the trunk, or on an extremity who were scheduled for sentinel node (SN) biop

299 proton and phosphorus MRI of the human lower extremities with high spatial and temporal resolution.

300 Treating posttraumatic lower extremity wounds can be challenging, especially in elder